Skip to content

Clinical trials

Phase 4 Insulin Resistance trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 4 Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20071
20081
20102
20111
20121
20131
20151
20161
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto3
Population Health Research Institute2
CHU de Quebec-Universite Laval1
Eli Lilly and Company1
Hamilton Health Sciences Corporation1
Jewish General Hospital1
LMC Diabetes & Endocrinology Ltd.1
Laval University1
University of Manitoba1
Vancouver General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance13
Diabetes Mellitus7
Diabetes Mellitus, Type 27
Diabetes Mellitus, Type 12
Overweight2
Body Weight1
Fatty Liver1
Metabolic Syndrome1
Obesity1
Pediatric Obesity1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.